Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
China VC Investment List Q3 2022 – Automotive
For automaking, we at EqualOcean have identified 20 companies worth watching in Q2. The core criterion is to receive venture capital investments of over USD 30 million on average or the equivalent value in CNY in a single round. When compiling the list, we also considered factors such as growth prospects, brand influences and reputation, as well as planned expansions.
Updated 25 mins ago
The Commercialization of The Domestic AI industry in 2022
Oct 05, 2022 09:00 AM
China's Road to Tackle Autoimmune Diseases Globally
Oct 04, 2022 08:00 AM
15 Chinese Companies to Watch in September 2022 – New Consumption
Oct 03, 2022 06:17 PM